BACKGROUND Decreasing oxidative damage with the antioxidant agent N-acetylcysteine (NAC) can block the side ramifications of chemotherapy, but may reduce anti-tumor efficacy. quantity to 3.9 2.3 mm3 in comparison to neglected tumor level of 45.9 38.7 (P = 0.008). Delayed NAC didn’t considerably alter cisplatin efficiency (tumor quantity 6.8 8.1 mm3, P = order E… Continue reading BACKGROUND Decreasing oxidative damage with the antioxidant agent N-acetylcysteine (NAC) can